Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagshealth BIO CEO & Investor Conference Food BIO Investor Forum Greenhouse Gas Emission vaccines global food crisis Patent Reform GMOs healthcare BIOTECH Benefits of biotech crops climate change Plant biotechnology International Sustainability Animal biotechnology biotechnology BIO EVENT agriculture
- Most Popular
- The Real Reason Why Salk Refused to Patent the Polio Vaccine
- What’s really hot in San Diego: Perspective from BIO 2017 Program Chair, Chris LeMasters
- Cancer Docs Weigh in on Medicare Part B Demo
- How Biotechnology is Helping Farmers and the Environment
- All Pharma Wants to Be “Patient-Centric” – What Does That Really Mean?